Skip Navigation

European Heart Journal 2001 22(16):1496-1503; doi:10.1053/euhj.2000.2547
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (46)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Williams, S.G
Right arrow Articles by Tan, L-B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, S.G
Right arrow Articles by Tan, L-B
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure

S.G Williamsf1, G.A Cooke, D.J Wright, W.J Parsons, R.L Riley, P Marshall and L-B Tan

Institute for Cardiovascular Research, Yorkshire Heart Centre, Leeds General Infirmary, Leeds, U.K.

revised November 14, 2000; accepted November 22, 2000

Abstract

Objectives This study assessed the prognostic value of peak cardiac power output, measured non-invasively during maximal cardiopulmonary exercise testing, against other exercise-derived haemodynamic variables in patients with chronic congestive heart failure.

Method and Results Two hundred and nineteen unselected, consecutive patients with congestive heart failure (166 men, mean (±SD) age of 56±13 years) who underwent maximal symptom limited cardiopulmonary treadmill exercise testing with non-invasive estimation of cardiac output using carbon dioxide re-breathing techniques, were followed-up for a mean period of 4·64 (4·47–4·82, 95% CI) years. Cardiac power output was calculated from the product of cardiac output and mean arterial blood pressure. All cause mortality was 12·3% (27 deaths). Peak and resting cardiac power output, peak mean arterial blood pressure, peak and resting cardiac output and peak VO2were all predictive of outcome on univariate analyses. Peak cardiac power output, either entered continuously or categorically with a cut-off value of 1·96 watts, was the only independent predictor of mortality (P=0·0004 for values <>1·96 watts and P=0·001 for continuous values) using multivariate analysis. A relative risk ratio of 5·08 (1·94–13·3, 95% CI) was obtained for a cardiac power output <1·96 watts.

Conclusion Peak cardiac power output is an independent predictor of mortality that can be measured non-invasively using cardiopulmonary exercise testing. It can give further prognostic power to a peak VO2in the assessment of patients with congestive heart failure.

Key Words: Chronic heart failure, cardiac power output, prognosis, non-invasive cardiopulmonary exercise testing

f1 Correspondence: Dr Lip-Bun Tan, Consultant Cardiologist, Institute for Cardiovascular Research, Yorkshire Heart Centre, Leeds General Infirmary, Leeds LS1 3EX, U.K.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
A. Patwala, P. Woods, R. Clements, K. Albouaini, A. Rao, D. Goldspink, L.-B. Tan, A. Oo, and D. Wright
A prospective longitudinal evaluation of the benefits of epicardial lead placement for cardiac resynchronization therapy
Europace, October 1, 2009; 11(10): 1323 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Cohen-Solal, F. Beauvais, and L.-B. Tan
Peak exercise responses in heart failure: back to basics
Eur. Heart J., June 26, 2009; (2009) ehp176v1.
[Full Text] [PDF]


Home page
Eur Heart JHome page
U. Corra, A. Mezzani, A. Giordano, E. Bosimini, and P. Giannuzzi
Exercise haemodynamic variables rather than ventilatory efficiency indexes contribute to risk assessment in chronic heart failure patients treated with carvedilol
Eur. Heart J., April 30, 2009; (2009) ehp138v1.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
C. C. Lang, P. Karlin, J. Haythe, T. K. Lim, and D. M. Mancini
Peak Cardiac Power Output, Measured Noninvasively, Is a Powerful Predictor of Outcome in Chronic Heart Failure
Circ Heart Fail, January 1, 2009; 2(1): 33 - 38.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
Y. Tayyareci, M. Sezer, B. Umman, S. Besisik, A. Mudun, Y. Sanli, A. Oncul, N. Gurses, D. Sargin, M. Meric, et al.
Intracoronary Autologous Bone Marrow-Derived Mononuclear Cell Transplantation Improves Coronary Collateral Vessel Formation and Recruitment Capacity in Patients With Ischemic Cardiomyopathy: A Combined Hemodynamic and Scintigraphic Approach
Angiology, May 1, 2008; 59(2): 145 - 155.
[Abstract] [PDF]


Home page
Eur J Heart FailHome page
M. J. Garcia-Gonzalez, A. Dominguez-Rodriguez, J. J. Ferrer-Hita, P. Abreu-Gonzalez, and M. B. Munoz
Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics
Eur J Heart Fail, November 1, 2006; 8(7): 723 - 728.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
D. Schlosshan, D. Barker, C. Pepper, G. Williams, C. Morley, and L.-B. Tan
CRT improves the exercise capacity and functional reserve of the failing heart through enhancing the cardiac flow- and pressure-generating capacity
Eur J Heart Fail, August 1, 2006; 8(5): 515 - 521.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Leitman, E. Sucher, E. Kaluski, R. Wolf, E. Peleg, Y. Moshkovitz, O. Milo-Cotter, Z. Vered, and G. Cotter
Non-invasive measurement of cardiac output by whole-body bio-impedance during dobutamine stress echocardiography: Clinical implications in patients with left ventricular dysfunction and ischaemia
Eur J Heart Fail, March 1, 2006; 8(2): 136 - 140.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. D. Chantler, R. E. Clements, L. Sharp, K. P. George, L.-B. Tan, and D. F. Goldspink
The influence of body size on measurements of overall cardiac function
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2059 - H2065.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. Thiele, P. Sick, E. Boudriot, K.-W. Diederich, R. Hambrecht, J. Niebauer, and G. Schuler
Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock
Eur. Heart J., July 1, 2005; 26(13): 1276 - 1283.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. G. Williams, L. L. Ng, R. J. O'Brien, S. Taylor, D. J. Wright, and L.-B. Tan
Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study
Eur J Heart Fail, December 1, 2004; 6(7): 891 - 900.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
U. Corra, A. Mezzani, E. Bosimini, and P. Giannuzzi
Cardiopulmonary Exercise Testing and Prognosis in Chronic Heart Failure*: A Prognosticating Algorithm for the Individual Patient
Chest, September 1, 2004; 126(3): 942 - 950.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Fincke, J. S. Hochman, A. M. Lowe, V. Menon, J. N. Slater, J. G. Webb, T. H. LeJemtel, G. Cotter, and SHOCK Investigators
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry
J. Am. Coll. Cardiol., July 21, 2004; 44(2): 340 - 348.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. Cotter, Y. Moshkovitz, E. Kaluski, A. J. Cohen, H. Miller, D. Goor, and Z. Vered
Accurate, Noninvasive Continuous Monitoring of Cardiac Output by Whole-Body Electrical Bioimpedance
Chest, April 1, 2004; 125(4): 1431 - 1440.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
G. Cotter, Y. Moshkovitz, E. Kaluski, O. Milo, Y. Nobikov, A. Schneeweiss, R. Krakover, and Z. Vered
The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure
Eur J Heart Fail, August 1, 2003; 5(4): 443 - 451.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Cotter, E. Kaluski, O. Milo, A. Blatt, A. Salah, A. Hendler, R. Krakover, A. Golick, and Z. Vered
LINCS: L-NAME (a NO synthase inhibitor) In the treatment of refractory Cardiogenic Shock: A prospective randomized study
Eur. Heart J., July 2, 2003; 24(14): 1287 - 1295.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. S. Hochman
Cardiogenic Shock Complicating Acute Myocardial Infarction: Expanding the Paradigm
Circulation, June 24, 2003; 107(24): 2998 - 3002.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. G. Burniston, Y. Ng, W. A. Clark, J. Colyer, L.-B. Tan, and D. F. Goldspink
Myotoxic effects of clenbuterol in the rat heart and soleus muscle
J Appl Physiol, November 1, 2002; 93(5): 1824 - 1832.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G.A. Cooke, S.G. Williams, P. Marshall, J.K. Al-Timman, J. Shelbourne, D.J. Wright, and L.-B. Tan
A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patients
Eur. Heart J., September 1, 2002; 23(17): 1360 - 1368.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D.P. Nicholls, C. O'Dochartaigh, and M.S. Riley
Circulatory power--a new perspective on an old friend
Eur. Heart J., August 2, 2002; 23(16): 1242 - 1245.
[PDF]


Home page
HeartHome page
D J Wright, S G Williams, R Riley, P Marshall, and L B Tan
Is early, low level, short term exercise cardiac rehabilitation following coronary bypass surgery beneficial? A randomised controlled trial
Heart, July 1, 2002; 88(1): 83 - 84.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D.P. Nicholls and M.S. Riley
Measuring cardiac power output--the acid test
Eur. Heart J., August 2, 2001; 22(16): 1368 - 1370.
[PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.